← Leaderboards
James Versalovic
Massachusetts General Hospital
$13,934,890
Attributed
$13,934,890
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,178,927 · 13
By mechanism
P30$4,737,563 · 4
UH3$3,344,970 · 1
R01$3,066,202 · 2
U01$2,801,410 · 1
R21$813,081 · 2
UH2$755,425 · 1
Top collaborators
- Hashem B El-Serag2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Allison Carey$2,921,568
- Filip K Swirski$20,484,870
- Bobby Joseph Cherayil$7,100,760
- Lael Yonker$2,492,132
- J Manuel Perez$2,482,363
Others in their field
Top investigators on “Intestines”
- Richard S Blumberg · Children'S Hospital Boston$45,768,173
- Mark Donowitz · Johns Hopkins University$37,125,295
- Israel David Goldman · Yeshiva University$32,031,336
- Samuel A Wells · Duke University$31,864,469
- Margaret Rita Karagas · Dartmouth College$30,262,431
- Abhik Das · Research Triangle Institute$30,240,510
Research focus
IntestinesBaseMicrobiomeGenesPathway InteractionsMicrobialAffectSignal TransductionResearch PersonnelMolecularInflammatory Bowel DiseasesGastrointestinalProductionMicrobeGene ExpressionResourcesGene Expression ProfilingProgramsPreventInflammatory Disease Of The IntestineGeneticBacteriaBiologySignal Pathway
Grant awards (46)
Functional Genomics & Microbiome Core$192,018
P30 · FY2025 · DK · contact PI
Functional Genomics & Microbiome Core$192,018
P30 · FY2024 · DK · contact PI
Functional Genomics & Microbiome Core$170,151
P30 · FY2023 · DK · contact PI
Functional Genomics & Microbiome Core$191,104
P30 · FY2022 · DK · contact PI
Functional Genomics & Microbiome Core$194,163
P30 · FY2021 · DK · contact PI
Texas Medical Center Digestive Diseases Center$1,110,570
P30 · FY2020 · DK
Functional Genomics & Microbiome Core$189,256
P30 · FY2020 · DK · contact PI
Texas Medical Center Digestive Diseases Center$1,133,467
P30 · FY2019 · DK
Functional Genomics & Microbiome Core$192,528
P30 · FY2019 · DK · contact PI
Functional Genomics & Microbiome Core$194,163
P30 · FY2018 · DK · contact PI
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia$452,105
U01 · FY2017 · CA · contact PI
FUNCTIONAL GENOMICS AND MICROBIOME CORE$195,625
P30 · FY2017 · DK · contact PI
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia$565,491
U01 · FY2016 · CA · contact PI
FUNCTIONAL GENOMICS AND MICROBIOME CORE$195,625
P30 · FY2016 · DK · contact PI
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia$584,586
U01 · FY2015 · CA · contact PI
FUNCTIONAL GENOMICS AND MICROBIOME CORE$195,625
P30 · FY2015 · DK · contact PI
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia$597,078
U01 · FY2014 · CA · contact PI
FUNCTIONAL GENOMICS AND MICROBIOME CORE$195,625
P30 · FY2014 · DK · contact PI
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia$602,150
U01 · FY2013 · CA · contact PI
FUNCTIONAL GENOMICS AND MICROBIOME CORE$195,625
P30 · FY2013 · DK · contact PI
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation$918,937
UH3 · FY2012 · DK · contact PI
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation$939,637
UH3 · FY2011 · DK · contact PI
Modulation of NF-kB Signaling by Immunoprobiotics$420,157
R01 · FY2011 · AT · contact PI
INFLUENCE OF DIET ON DEVELOPMENT OF INTESTINAL MICROBIOTA$20,481
M01 · FY2011 · RR · contact PI
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation$1,486,396
UH3 · FY2010 · DK · contact PI
Modulation of NF-kB Signaling by Immunoprobiotics$431,177
R01 · FY2010 · AT · contact PI
Intestinal Lactobacillus and Mucosal Immunomodulation$303,883
R01 · FY2010 · DK · contact PI
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation$755,425
UH2 · FY2009 · DK · contact PI
Modulation of NF-kB Signaling by Immunoprobiotics$458,358
R01 · FY2009 · AT · contact PI
Intestinal Lactobacillus and Mucosal Immunomodulation$336,058
R01 · FY2009 · DK · contact PI
Intestinal Lactobacillus and Mucosal Immunomodulation$1,535
R01 · FY2009 · DK · contact PI
Modulation of NF-kB Signaling by Immunoprobiotics$457,889
R01 · FY2008 · AT · contact PI
Intestinal Lactobacillus and Mucosal Immunomodulation$316,661
R01 · FY2008 · DK · contact PI
Probiotic Lactobacillus-Mediated Suppression of TNF in Pediatric Crohn's Disease$220,500
R21 · FY2008 · AT · contact PI
Intestinal Lactobacillus and Mucosal Immunomodulation$20,919
R01 · FY2008 · DK · contact PI
Intestinal Lactobacillus and Mucosal Immunomodulation$319,565
R01 · FY2007 · DK · contact PI
Probiotic Lactobacillus-Mediated Suppression of TNF in Pediatric Crohn's Disease$187,500
R21 · FY2007 · AT · contact PI
Reuteri LuxS in Probiosis for Early Childhood Caries$180,081
R21 · FY2006 · DE · contact PI
Reuteri LuxS in Probiosis for Early Childhood Caries$225,000
R21 · FY2005 · DE
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$1,080
K08 · FY2005 · DK
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$129,951
K08 · FY2004 · DK
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$129,951
K08 · FY2003 · DK
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$129,951
K08 · FY2002 · DK
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$86,306
K08 · FY2001 · DK
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$38,245
K08 · FY2001 · DK
CATALASE IMMUNITY IN PRIMARY SCLEROSING CHOLANGITIS$124,311
K08 · FY2000 · DK